WallStreetZenWallStreetZen

NASDAQ: CTNM
Contineum Therapeutics Inc Stock Ownership - Who owns Contineum Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Contineum Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daniel S. LorrainChief Scientific Officer2026-05-01300$13.84
$4.15kSell
Daniel S. LorrainChief Scientific Officer2026-05-013,870$13.06
$50.54kSell
Daniel S. LorrainChief Scientific Officer2026-04-064,170$13.43
$56.02kSell
Tim WatkinsCMO Head of Development2026-03-023,611$15.02
$54.22kSell
Daniel S. LorrainChief Scientific Officer2026-03-024,170$15.01
$62.58kSell
Tim WatkinsCMO Head of Development2026-03-023,611$4.50
$16.25kBuy
Carmine N. StengoneCEO and President2026-02-252,700$16.02
$43.24kSell
Daniel S. LorrainChief Scientific Officer2026-02-253,824$1.01
$3.86kBuy
Daniel S. LorrainChief Scientific Officer2026-02-253,824$16.01
$61.23kSell
Carmine N. StengoneCEO and President2026-02-252,700$1.26
$3.40kBuy

1 of 3

CTNM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTNM insiders and whales buy or sell their stock.

CTNM Shareholders

What type of owners hold Contineum Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Johnson Johnson5.29%1,979,173$28.12MInsider
Vanguard Capital Management LLC3.25%1,214,173$17.25MInstitution
Red Tree Management LLC1.71%638,158$9.07MInstitution
Versant Venture Management LLC1.45%542,628$7.71MInstitution
Versant Venture Capital VI LP1.40%523,847$7.44MInsider
Ubs Group Ag0.62%230,409$3.27MInstitution
Vanguard Fiduciary Trust Co0.41%153,924$2.19MInstitution
Daniel S. Lorrain0.40%150,384$2.14MInsider
Jane Street Group LLC0.29%107,380$1.53MInstitution
Dimensional Fund Advisors LP0.16%59,946$851.83kInstitution

1 of 3

CTNM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTNM8.19%7.17%Net SellingNet Selling
AGMB14.24%0.09%
PRTA15.54%81.69%
DNA5.29%94.71%Net SellingNet Selling
XOMA3.20%96.80%Net BuyingNet Buying
View Top Biotech Stocks

Contineum Therapeutics Stock Ownership FAQ

Who owns Contineum Therapeutics?

Contineum Therapeutics (NASDAQ: CTNM) is owned by 8.19% institutional shareholders, 7.17% Contineum Therapeutics insiders, and 84.64% retail investors. Johnson Johnson is the largest individual Contineum Therapeutics shareholder, owning 1.98M shares representing 5.29% of the company. Johnson Johnson's Contineum Therapeutics shares are currently valued at $27.15M.

If you're new to stock investing, here's how to buy Contineum Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.